Brainsway (BRSYF) EBT Margin (2018 - 2026)
Brainsway's (BRSYF) quarterly EBT Margin came in at 17.06% in Q2 2026, up 46.0% on a YoY basis from 11.68% in Q2 2025, and up 9.92% quarter-over-quarter from 15.52% in Q1 2026.
Powered by 
Analysis
Brainsway (BRSYF) EBT Margin (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported EBT Margin for 9 consecutive years, with 17.06% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 46.0% year-over-year to 17.06%; the trailing twelve-month figure through Jun 2026 stood at 15.94% (up 328.0% YoY), and the FY2025 full-year result was 14.76%, up 633.0% from the prior year.
- EBT Margin advanced to 17.06% in Q2 2026 per BRSYF's latest filing, from 15.52% in the prior quarter.
- Across five years, EBT Margin topped out at 17.47% in Q4 2025 and bottomed at 96.15% in Q3 2022.
- Historically, EBT Margin has averaged 8.06% across 5 years, with a median of 5.06% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 7639 bps in 2022, then jumped 9409 bps in 2023.
- Over 5 years, EBT Margin stood at 65.01% in 2022, then surged by 99 bps to 0.41% in 2023, then surged by 3812 bps to 15.21% in 2024, then rose by 15 bps to 17.47% in 2025, then declined by 2 bps to 17.06% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 17.06%, 15.52%, and 17.47% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 18.32% |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 17.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.06% |
| Mar 31, 2026 | 15.52% |
| Dec 31, 2025 | 17.47% |
| Sep 30, 2025 | 13.38% |
| Jun 30, 2025 | 16.60% |
| Mar 31, 2025 | 10.96% |
| Dec 31, 2024 | 15.21% |
| Sep 30, 2024 | 7.02% |
| Jun 30, 2024 | 7.03% |
| Mar 31, 2024 | 3.11% |
| Dec 31, 2023 | -0.41% |
| Sep 30, 2023 | -2.06% |
| Jun 30, 2023 | -18.88% |
| Mar 31, 2023 | -34.11% |
| Dec 31, 2022 | -65.01% |
| Sep 30, 2022 | -96.15% |
| Jun 30, 2022 | -29.19% |
| Mar 31, 2022 | -22.66% |
| Dec 31, 2021 | -21.62% |
| Sep 30, 2021 | -19.76% |